Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETASERON for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 71 adverse event reports in the FDA FAERS database where BETASERON was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for BETASERON

Side Effect Reports % Deaths Hosp.
Influenza like illness 65 11.0% 0 2
Injection site pain 43 7.3% 0 3
Drug ineffective 41 6.9% 0 0
Multiple sclerosis relapse 41 6.9% 1 8
Multiple sclerosis 38 6.4% 1 5
Injection site erythema 35 5.9% 0 1
Depression 33 5.6% 0 2
Fatigue 29 4.9% 0 2
Drug dose omission 22 3.7% 0 5
Injection site bruising 22 3.7% 0 2
Injection site mass 22 3.7% 0 1
Injection site reaction 22 3.7% 0 0
Hypoaesthesia 21 3.6% 0 4
Gait disturbance 20 3.4% 0 0
Chills 19 3.2% 0 1

Other Indications for BETASERON

Multiple sclerosis (367) Product used for unknown indication (19) Secondary progressive multiple sclerosis (7)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

BETASERON Full Profile All Relapsing-remitting multiple sclerosis Drugs BETASERON Demographics BETASERON Timeline